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The inhibitory specificity of a protein from potato tubers that inhibits cysteine proteinases (potato cysteine proteinase inhibitor, PCPI) has been 
compared with that of chicken egg-white cystatin. Most proteinases that are inhibited by cystatin were also inhibited by PCPI, but the potato 
inhibitor inhibited stem bromelain and fruit bromelain, which are not inhibited by cystatin, and for which no protein inhibitor of comparable 
potency has previously been described. In contrast, papaya proteinase IV was unaffected by PCPI as it is by the cystatins, and the exopeptidase, 
dipeptidyl pcptidase I, is inhibited by cystatins, but was unaffected by PCPI. The differences in inhibitory specificity between these proteins may 
well reflect differences between superfamilies of cysteine proteinase inhibitors. 
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1. INTRODUCTION 2. EXPERIMENTAL 
2.1. Materials 
Potato tubers are known to contain a number of pro- 
tein inhibitors of endopeptidases, including inhibitors 
of serine proteinases [l], and an inhibitor of the aspartic 
proteinase, cathepsin D, which has been found to be 
structurally related to soybean trypsin inhibitor [2]. 
Several inhibitors of cysteine proteinases which also 
belong to the same structural superfamily [3] have 
recently been isolated and partially characterized from 
potato peelings [4]. These proteins all had M, values of 
about 23000, but differed in p1. They also differed in 
their effectiveness of inhibition of various cysteine pro- 
teinases [3]. The potato cysteine proteinase inhibitor 
variant of p1 8.3 (PCPI 8.3), which was isolated as a 
homogeneous protein lacking any inhibitory activity for 
trypsin or chymotrypsin [3,4], has now been more fully 
characterized as an inhibitor of cysteine proteinases, 
and the results are here compared to those for an in- 
hibitor from the cystatin superfamily, chicken egg- 
white cystatin. 
Z-Arg-NHMec, Z-Arg-Arg-NHMec, Z-Phe-Arg-NHMec, Bz-Phe- 
Val-Arg-NHMec and Gly-Phe-NHMec were from Bachem Fein- 
chemikalien, Bubendorf, Switzerland. Boc-Ala-Ala-Gly-NHMec was 
the gift of Dr C.G. Knight (Strangeways Research Laboratory). 
PCPI 8.3 was prepared as described elsewhere [4]. The active molar 
concentration of PCPI 8.3 was determined by titration with ananain, 
which itself had been previously standardized by titration with Com- 
pound E-65 [S], using Bz-Phe-Val-Arg-NHPhNOz as substrate accor- 
ding to the method of [6]. Chicken egg-white cystatin was purified [7] 
and titrated as described elsewhere [5]. 
Clostripain (cat. no. COSSS), dipeptidyl peptidase I (cat. no. 
C8511), papain (cat. no. P3152) and ficin (cat. no. F4125) were from 
Sigma. Ananain and stem bromelain [5], fruit bromelain and pingui- 
nain [8], actinidin [9], papaya proteinase III [6], papaya proteinase IV 
[lo], and sheep cathepsin L [11,12] were purified as previously 
described. Human liver cathepsin B was prepared as described [13] ex- 
cept that the affinity ligand used was phenylalanylaminoacetaldehyde 
semicarbazone. Chymopapain was prepared as described [ 141. 
2.2. Determination of Ki values 
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K, (app) values for the interaction between PCPI 8.3 and the various 
cysteine proteinases were determined by use of continuous 
fluorimetric assays. Fluorescence (excitation 360 nm, emission 460 
nm) was monitored in a fluorimeter (Perkin-Elmer LS-3B) fitted with 
a temperature-controlled cell with magnetic stirrer, and connected to 
an IBM-compatible computer unning the FLU software system [ 151. 
Enzyme was allowed to activate in 0.75 ml of assay buffer (see below) 
for 5 min at assay temperature, and then prewarmed 0.01% Brij 35 
was added, followed by substrate (see below), to a final volume of 3.0 
ml. The rate of the reaction in the absence of inhibitor (V,) was 
recorded, and inhibitor (ranging from 2.5 X lo-ii to 5 X lo-’ M 
final concentration of active PCPI 8.3, depending on the enzyme) was 
added in a negligible volume. The initial rate was allowed to relax to 
a new steady state (vi). Non-linear regression analysis of the replot of 
fractional activity (vi/v,) versus inhibitor concentration [la] gave 
Ki ( app). The K, value was obtained from the relationship: 
K, = Ki(a,v)/(l + [al/Km) 
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Table I Table II 
Substrate concentrations used for the determination of Ki with PCPI 
8.3 
Comparison of Ki values for inhibition of cysteine proteinases and 
dipeptidyl peptidase I by PCPI 8.3 and chicken cystatin 
Substrate Enzyme [Sl (IrM) 
Z-Arg-NHMec clostripain 5 
Z-Arg-Arg-NHMec cathepsin B 10 
stem bromelain 5 
Z-Phe-Arg-NHMec actinidin, ficin 5 
papain, cathepsin L, 
papaya proteinase III, 2 
chymopapain 1 
Bz-Phe-Val-Arg-NHMec ananain 5 
fruit bromelain 4 
pinguinain 2 
Boc-Ala-Ala-Gly-NHMec papaya proteinase IV 5 
Gly-Phe-NHMec dipeptidyl peptidase I 250 
The substrate concentrations[S] were chosen such that [S] < Km, in 
all cases, K,,, values (not shown) having been determined in 
preliminary experiments. 
For the plant proteinases, the assay buffer was 0.40 M sodium 
phosphate buffer, pH 6.8. With cathepsin B, a 0.25 M 2-(N- 
morpholino)ethanesulphonic a id buffer, pH 5.5, was used, and for 
cathepsin L, 0.40 M sodium acetate buffer, pH 5.5, was used. All the 
above assay buffers contained 16 mM cysteine and 4 mM EDTA. 
Clostripain and dipeptidyl peptidase I were assayed as described 
previously [17] at 25 and 37”C, respectively, apart from the use of Z- 
Arg-MHMec as substrate for clostripain. The plant enzymes were 
assayed at 40°C, the cathepsins at 30°C. The substrates were used at 
final concentrations given in Table I. 
Proteinase Ki (nM) 
PCPI 8.3 Cystatin 
Ananain 0.06 1.1 151 
Cathepsin L 0.07 0.02’ WI 
Papain 3.3 0.005 I181 
Actinidin 27 5 I211 
Fruit bromelain 33 >>llOO I81 
Pinguinain 35 1.6 Is1 
Papaya proteinase III 150 732 
Stem bromelain 190 >36000 151 
Ficin 2103 0.00005 ]211 
Chymopapain 210 0.33 1101 
Cathepsin B 320 0.81 I221 
Papaya proteinase IV >>500 >>1130 1101 
Clostripain >>500 >5004 
Dipeptidyl peptidase I >>500 0.35 1181 
Values of Ki for PCPI 8.3 were determined as described in the Ex- 
perimental section. The enzymes are ranked in order of increasing Ki 
with PCPI 8.3, and literature values for chicken cystatin are given for 
comparison. 
‘For human cathepsin L; *D.J. Buttle and R. Feltell, unpublished 
results; ‘this value should be regarded as an estimate only, since the 
enzyme preparation used was heterogeneous (results not shown); 
4approx. 50% inhibition of clostripain was obtained at cystatin con- 
centrations from 0.5-1.5 PM, as observed previously [23], suggesting 
heterogeneity of the commercial enzyme preparation. 
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3. RESULTS AND DISCUSSION 
The inhibitory spectrum of PCPI 8.3 for cysteine en- 
dopeptidases (Table II) is remarkably broad, including 
two enzymes, stem bromelain and fruit bromelain, that 
are not inhibited by chicken egg-white cystatin, and for 
which no protein inhibitor of comparable potency has 
previously been described. On the other hand, the 
cysteine-dependent exopeptidase, dipeptidyl peptidase 
I, which is well inhibited by several cystatin-type in- 
hibitors [18], was not detectably inhibited by PCPI. 
Also, papaya proteinase IV, perhaps the most specific 
known member of the papain superfamily [19] was 
unaffected by PCPI 8.3, as it is by the cystatins [20]. 
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